retatrutide clinical trials retatrutide what is Retatrutide: The Triple Agonist That Could Redefine Metabolic Medicine (a full breakdown from a clinical Retatrutide Retatrutide Dosing Schedule: Proven 2026

Beyond that, a head-to-head comparison from the SURMOUNT-5 trial illustrates the difference clearly: Participants taking tirzepatide lost an average of 20.2% of their body weight compared to 13.7% with semaglutide

Common injection areas include the abdomen, thigh, or upper arm, and our medical team will guide you in proper injection technique to ensure comfort and effectiveness

Also GLP1RAs have been found to decrease epicardial fat, which may help explain their potential in lowering the risk of atherosclerosis

At Reset IV, we prioritize ensuring you receive a treatment that meets the highest safety standards, using only top-of-the-line sterile equipment